Correlation Between Cumberland Pharmaceuticals and 893647BL0

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cumberland Pharmaceuticals and 893647BL0 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumberland Pharmaceuticals and 893647BL0 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cumberland Pharmaceuticals and TransDigm 55 percent, you can compare the effects of market volatilities on Cumberland Pharmaceuticals and 893647BL0 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumberland Pharmaceuticals with a short position of 893647BL0. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumberland Pharmaceuticals and 893647BL0.

Diversification Opportunities for Cumberland Pharmaceuticals and 893647BL0

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cumberland and 893647BL0 is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and TransDigm 55 percent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TransDigm 55 percent and Cumberland Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumberland Pharmaceuticals are associated (or correlated) with 893647BL0. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TransDigm 55 percent has no effect on the direction of Cumberland Pharmaceuticals i.e., Cumberland Pharmaceuticals and 893647BL0 go up and down completely randomly.

Pair Corralation between Cumberland Pharmaceuticals and 893647BL0

Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to generate 13.88 times more return on investment than 893647BL0. However, Cumberland Pharmaceuticals is 13.88 times more volatile than TransDigm 55 percent. It trades about 0.12 of its potential returns per unit of risk. TransDigm 55 percent is currently generating about -0.07 per unit of risk. If you would invest  130.00  in Cumberland Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of  109.50  from holding Cumberland Pharmaceuticals or generate 84.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy96.88%
ValuesDaily Returns

Cumberland Pharmaceuticals  vs.  TransDigm 55 percent

 Performance 
       Timeline  
Cumberland Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cumberland Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Cumberland Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
TransDigm 55 percent 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TransDigm 55 percent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 893647BL0 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Cumberland Pharmaceuticals and 893647BL0 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cumberland Pharmaceuticals and 893647BL0

The main advantage of trading using opposite Cumberland Pharmaceuticals and 893647BL0 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumberland Pharmaceuticals position performs unexpectedly, 893647BL0 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 893647BL0 will offset losses from the drop in 893647BL0's long position.
The idea behind Cumberland Pharmaceuticals and TransDigm 55 percent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas